Safety & Regulations
Safety standards, patient screening, laboratory controls, regulation, risks and limitations in regenerative medicine.
Safety begins with individual screening
Regenerative medicine procedures require a documented review of diagnosis, medical history, current medication, laboratory findings, imaging, contraindications and available treatment alternatives. A procedure should not be recommended solely from an online description.
Cell and laboratory quality controls
- Documented origin and traceability of biological material
- Donor eligibility and screening where donor material is considered
- Identity, viability, sterility and microbiological controls appropriate to the product
- Controlled handling, storage and transportation
- Protocol-specific preparation and clinical documentation
Clinical safeguards
- Medical eligibility assessment and contraindication review
- Informed consent covering alternatives, uncertainty, risks and limitations
- Administration in an appropriate clinical setting
- Observation, adverse-event procedures and follow-up planning
Regulation depends on location
Legal classifications, permitted cell sources, laboratory requirements and clinical uses differ by country and treatment location. The coordinating team must confirm which clinic, laboratory and protocol are applicable before treatment is arranged.
Risks and limitations
No outcome can be guaranteed. Potential risks depend on the cell product, route of administration, medical condition and patient health. These may include infection, inflammatory or immune reactions, bleeding, thrombosis, procedure-related complications, lack of benefit and other condition-specific risks.